Palliative chemotherapy with or without anti-EGFR therapy for de novo metastatic nasopharyngeal carcinoma: a propensity score-matching study

OBJECTIVE: We aimed to investigate the efficacy and safety of cetuximab (CTX) or nimotuzumab (NTZ) on the addition of palliative chemotherapy (PCT) in patients with de novo metastatic nasopharyngeal carcinoma (NPC). MATERIALS AND METHODS: From 2007 to 2016, 451 eligible patients with de novo metasta...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Drug Des Devel Ther
Auteurs principaux: Sun, Xue-Song, Liang, Yu-Jing, Li, Xiao-Yun, Liu, Sai-Lan, Chen, Qiu-Yan, Tang, Lin-Quan, Mai, Hai-Qiang
Format: Artigo
Langue:Inglês
Publié: Dove 2019
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6751225/
https://ncbi.nlm.nih.gov/pubmed/31686783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S215190
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires